452 related articles for article (PubMed ID: 34211157)
1. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.
Giraldez MD; Carneros D; Garbers C; Rose-John S; Bustos M
Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):787-803. PubMed ID: 34211157
[TBL] [Abstract][Full Text] [Related]
2. Treatment of type 2 diabetes with the designer cytokine IC7Fc.
Findeisen M; Allen TL; Henstridge DC; Kammoun H; Brandon AE; Baggio LL; Watt KI; Pal M; Cron L; Estevez E; Yang C; Kowalski GM; O'Reilly L; Egan C; Sun E; Thai LM; Krippner G; Adams TE; Lee RS; Grötzinger J; Garbers C; Risis S; Kraakman MJ; Mellet NA; Sligar J; Kimber ET; Young RL; Cowley MA; Bruce CR; Meikle PJ; Baldock PA; Gregorevic P; Biden TJ; Cooney GJ; Keating DJ; Drucker DJ; Rose-John S; Febbraio MA
Nature; 2019 Oct; 574(7776):63-68. PubMed ID: 31554967
[TBL] [Abstract][Full Text] [Related]
3. The gp130 receptor cytokine family: regulators of adipocyte development and function.
White UA; Stephens JM
Curr Pharm Des; 2011; 17(4):340-6. PubMed ID: 21375496
[TBL] [Abstract][Full Text] [Related]
4. IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes.
Skuratovskaia D; Komar A; Vulf M; Quang HV; Shunkin E; Volkova L; Gazatova N; Zatolokin P; Litvinova L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579000
[TBL] [Abstract][Full Text] [Related]
5. The role of gp130 receptor cytokines in the regulation of metabolic homeostasis.
Cron L; Allen T; Febbraio MA
J Exp Biol; 2016 Jan; 219(Pt 2):259-65. PubMed ID: 26792338
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
7. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
[TBL] [Abstract][Full Text] [Related]
8. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.
Waetzig GH; Chalaris A; Rosenstiel P; Suthaus J; Holland C; Karl N; Vallés Uriarte L; Till A; Scheller J; Grötzinger J; Schreiber S; Rose-John S; Seegert D
J Biol Chem; 2010 Jan; 285(3):1781-9. PubMed ID: 19915009
[TBL] [Abstract][Full Text] [Related]
9. The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
De Vries LCS; Wildenberg ME; De Jonge WJ; D'Haens GR
J Crohns Colitis; 2017 Jul; 11(7):885-893. PubMed ID: 28158411
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
[TBL] [Abstract][Full Text] [Related]
11. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
[TBL] [Abstract][Full Text] [Related]
12. Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.
Sreenivasan L; Li LV; Leclair P; Lim CJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
[TBL] [Abstract][Full Text] [Related]
13. IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases.
Zhao J; Turpin-Nolan S; Febbraio MA
Cytokine; 2021 Aug; 144():155549. PubMed ID: 33962843
[TBL] [Abstract][Full Text] [Related]
14. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM
J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229
[TBL] [Abstract][Full Text] [Related]
15. Targeting the glycoprotein 130 receptor subunit to control pain and inflammation.
Jazayeri JA; Upadhyay A; Vernallis AB; Carroll GJ
J Interferon Cytokine Res; 2010 Dec; 30(12):865-73. PubMed ID: 20979530
[TBL] [Abstract][Full Text] [Related]
16. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
[TBL] [Abstract][Full Text] [Related]
17. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.
White UA; Stewart WC; Stephens JM
Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.
Haan C; Heinrich PC; Behrmann I
Biochem J; 2002 Jan; 361(Pt 1):105-11. PubMed ID: 11742534
[TBL] [Abstract][Full Text] [Related]
19. A directly GP130-targeting small molecule ameliorates collagen-induced arthritis (CIA) by inhibiting IL-6/GP130 signalling and Th17 differentiation.
Park YH; Kim HJ; Heo TH
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):628-639. PubMed ID: 31742738
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
